微畔官网-助力百万同学,实现人生梦想
微畔官网

AtomTherapeuticsCo.Ltd.,aclinicalstagebiotechnologycompanyfoundedin2012,isdevelopingbest-in-classsmallmoleculedrugsfortreatmentofmetabolic,inflammatoryandcardiovasculardiseases.Atom’sleadproduct,ABP-671,isinmulticenterPhase2b/3clinicaltrialsworldwide,includingtheUS,fortreatmentofchronicgoutandhyperuricemia.ABP-671hasshowngoodefficacy,safetyand[…]